| 1 |
28267564 | Development of 17β-hydroxysteroid dehydrogenase type 3 as a target in hormone-dependent prostate cancer therapy. | 2017 May |
1 |
| 2 |
23132791 | STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer model. | 2013 Feb |
1 |
| 3 |
23435447 | The 17β-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literature. | 2013 Mar |
1 |
| 4 |
21741247 | Development of 3-substituted-androsterone derivatives as potent inhibitors of 17β-hydroxysteroid dehydrogenase type 3. | 2011 Aug 1 |
1 |
| 5 |
18786604 | Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3. | 2009 Mar 25 |
1 |
| 6 |
15745934 | Novel insertion frameshift mutation of the LH receptor gene: problematic clinical distinction of Leydig cell hypoplasia from enzyme defects primarily affecting testosterone biosynthesis. | 2005 Feb |
1 |
| 7 |
15924334 | Identification of novel functional inhibitors of 17beta-hydroxysteroid dehydrogenase type III (17beta-HSD3). | 2005 Oct 1 |
2 |